TRAVERSA SERGIO (Chief Executive Officer) purchased 15.4% of their position (200K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $828.0K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/11/2026ACC: 0001213900-26-098969
DirectorOfficer· Chief Executive Officer
Since Dec 2018
+200K
Net shares
Net buyer
$828.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
200K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+100K
Price / share
$4.18
Trade value
$418K
% of position
7.7%
9/9/2026
1.30M→1.40M
Common Stock
Direct
Shares
+100K
Price / share
$4.10
Trade value
$410K
% of position
7.1%
9/10/2026
1.40M→1.50M
Total
Net shares
+200K
Net value
$828K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2026 | P · Purchase | +100K | $4.18 | $418K | 7.7% | 1.30M | 1.40M |
| Common Stock Direct | 9/10/2026 | P · Purchase | +100K | $4.10 | $410K | 7.1% | 1.40M | 1.50M |
| Total | +200K | $828K | ||||||
Derivative Transactions0
No derivative transactions reported